USG, North America's largest producer of gypsum wallboard, has had an ugly past but a positive future lies ahead. After spending the last five years in bankruptcy, due to asbestos litigation, USG is now out of Chapter 11 and making money- steered by first-rate management. Rogers has "recently bought the stock at a 27% discount to his $67 estimate. Once housing bounces back, so should the demand for USG's Sheetrock."

Herman Miller, office furniture manufacturer- most known for creating the office cubicle, trades around $37. Sales plummeted last recession but are gaining back at a double-digit rate. MLHR expansion into the education and health care sector along with large order backlog should produce substantial profits going forward. Shares are priced at a 10% discount to Roger's $41 estimate of intrinsic worth.

Rogers also likes Bio-Rad Laboratories, a medical research and diagnostic producer whose tests devices are used for food pathogens, mad cow disease, blood viruses and genetic disorders. BIO is trading at $69, 20% off of Rogers' market value estimate of $86. Bio-Rad strictly invests long term and has been in the midst of recent acquisitions, which can account for depressed 2007 earnings. But annual revenues are steadily growing.